A randomised, double-blind, double-dummy, oral donepezil controlled study on the safety and efficacy of repeated monthly subcutaneous injections of a sustained-release implant of ZT 1 [DEBIO 9902; Debiopharm] in patients with moderate Alzheimer's disease.

Trial Profile

A randomised, double-blind, double-dummy, oral donepezil controlled study on the safety and efficacy of repeated monthly subcutaneous injections of a sustained-release implant of ZT 1 [DEBIO 9902; Debiopharm] in patients with moderate Alzheimer's disease.

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Jan 2017

At a glance

  • Drugs Mimopezil (Primary) ; Donepezil
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms BRAINz
  • Most Recent Events

    • 30 Oct 2009 Additional lead trial investigator Wilkinson D identified as reported by United Kingdom Clinical Research Network record.
    • 22 Sep 2009 Actual end date changed from June 2009 to Sep 2009 as reported by ClinicalTrials.gov.
    • 12 Jul 2009 Results presented at the 2009 International Conference on Alzheimer's Disease (ICAD).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top